C-Bond Systems Past Earnings Performance
Past criteria checks 0/6
C-Bond Systems has been growing earnings at an average annual rate of 33.1%, while the Chemicals industry saw earnings growing at 9.5% annually. Revenues have been growing at an average rate of 36.8% per year.
Key information
33.1%
Earnings growth rate
53.2%
EPS growth rate
| Chemicals Industry Growth | 12.9% |
| Revenue growth rate | 36.8% |
| Return on equity | n/a |
| Net Margin | -70.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How C-Bond Systems makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 3 | -2 | 4 | 0 |
| 30 Jun 24 | 3 | -2 | 3 | 0 |
| 31 Mar 24 | 3 | 2 | 4 | 0 |
| 31 Dec 23 | 2 | 2 | 3 | 0 |
| 30 Sep 23 | 2 | 2 | 3 | 0 |
| 30 Jun 23 | 2 | 1 | 3 | 0 |
| 31 Mar 23 | 2 | -4 | 3 | 0 |
| 31 Dec 22 | 2 | -5 | 4 | 0 |
| 30 Sep 22 | 2 | -5 | 5 | 0 |
| 30 Jun 22 | 2 | -6 | 5 | 0 |
| 31 Mar 22 | 2 | -6 | 5 | 0 |
| 31 Dec 21 | 1 | -12 | 8 | 0 |
| 30 Sep 21 | 1 | -14 | 8 | 0 |
| 30 Jun 21 | 1 | -11 | 8 | 0 |
| 31 Mar 21 | 1 | -12 | 9 | 0 |
| 31 Dec 20 | 1 | -6 | 5 | 0 |
| 30 Sep 20 | 1 | -4 | 4 | 0 |
| 30 Jun 20 | 0 | -6 | 5 | 0 |
| 31 Mar 20 | 1 | -6 | 5 | 0 |
| 31 Dec 19 | 1 | -7 | 7 | 0 |
| 30 Sep 19 | 1 | -8 | 8 | 0 |
| 30 Jun 19 | 0 | -9 | 9 | 0 |
| 31 Mar 19 | 0 | -10 | 9 | 0 |
| 31 Dec 18 | 0 | -10 | 9 | 0 |
| 30 Sep 18 | 0 | -13 | 12 | 0 |
| 30 Jun 18 | 0 | -11 | 11 | 0 |
| 31 Mar 18 | 0 | -10 | 10 | 0 |
| 31 Dec 17 | 0 | -8 | 8 | 0 |
| 31 Dec 16 | 1 | -6 | 6 | 0 |
Quality Earnings: CBNT is currently unprofitable.
Growing Profit Margin: CBNT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CBNT is unprofitable, but has reduced losses over the past 5 years at a rate of 33.1% per year.
Accelerating Growth: Unable to compare CBNT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CBNT is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (4.8%).
Return on Equity
High ROE: CBNT's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.